SCHEMBL8070403

SCHEMBL8070403

CN1CCN(CNCC(C)(C)C)CC1

nearest known ligand 0.35

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HRH4 Q9H3N8 4/20 0.35
HRH3 Q9Y5N1 2/20 0.35
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
MAPT P10636 1/20 0.33
RECQL P46063 1/20 0.33
HTT P42858 1/20 0.33
MC4R P32245 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
CSNK2A2 P19784 1/20 0.30
CSNK2B P67870 1/20 0.30
CSNK2A1 P68400 1/20 0.30
CSNK2A3 Q8NEV1 1/20 0.30
CYP1A2 P05177 1/20 0.30
CYP2D6 P10635 1/20 0.30
TMEM97 Q5BJF2 1/20 0.30
SIGMAR1 Q99720 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4393264 0.81 NPSR1 (0.39) HTTMC4RNPSR1CSNK2A2CSNK2B
SCHEMBL25043342 0.73 ALDH1A1 (0.35) KDM4EALDH1A1MAPTRECQLHTT
SCHEMBL8398744 0.71 KDM4E (0.37) HRH4KDM4EALDH1A1MC4RNPSR1
SCHEMBL15827533 0.70 MC4R (0.31) ALDH1A1MC4RNPSR1CSNK2A2CSNK2B
SCHEMBL26455581 0.69 HTT (0.41) HRH4KDM4EALDH1A1MAPTRECQL
SCHEMBL792900 0.69 CARM1 (0.39) KDM4EMC4RNPSR1CSNK2A2CSNK2B
SCHEMBL736240 0.69 HTT (0.41) HRH4KDM4EALDH1A1MAPTRECQL
SCHEMBL2296486 0.68
SCHEMBL8059112 0.67 SIGMAR1 (0.50) KDM4EALDH1A1SIGMAR1
SCHEMBL22066263 0.67 LMNA (0.38) MC4RNPSR1CSNK2A2CSNK2BCSNK2A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080132500-A1 Antibiotic compounds MERCK SHARP & DOHME CORP. 2008-06-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080132500-A1 Antibiotic compounds NRDC, MRPL21, PEPD HRH4 2806/4885HRH3 3790/4885KDM4E 4740/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.